Desvenlafaxine

🧮 Dose calculator

Major depressive disorder · Regimen source: FDA Desvenlafaxine · 2.1

• • 50 mg is both the starting and therapeutic dose; higher doses showed no extra benefit. Taper on stopping (25 mg is for tapering). FDA Desvenlafaxine · 2.1FDA Desvenlafaxine · 2.5

Enter age (weight is optional for this regimen).

👥 Special populations

• 🤰 PregnancyUse with caution

  Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Desvenlafaxine · 8.1

  “Risk Summary Based on data from published observational studies, exposure to SNRIs, particularly in the month before delivery, has been associated with a less than 2-fold increase in the risk of postpartum hemorrhage [see Warnings and Precautions (5.4) and Clinical Considerations].”

• 🤱 BreastfeedingUse with caution

  Label: use with caution while breastfeeding; see the label text. FDA Desvenlafaxine · 8.2

  “Risk Summary Available limited data from published literature show low levels of desvenlafaxine in human milk, and have not shown adverse reactions in breastfed infants (see Data) .”

• 👶 ChildrenDangerous / avoid

  Boxed warning in the label about children. FDA Desvenlafaxine · Boxed Warning

  “Desvenlafaxine extended-release tablets are not approved for use in pediatric patients [see Use in Specific Populations (8.4) ] .”

• 👴 Older adultsUse with caution

  Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Desvenlafaxine · 8.5

  “… ly significant hyponatremia in elderly patients, who may be at greater risk for this adverse event [see Warnings and Precautions (5.9) ] .”

• ⚥ Females & males of reproductive potentialNo data

  The source for this drug has no section for this group.